Ping An concludes clinical study for worlds first OCT retinal disease screening system

Ping An concludes clinical study for world’s first OCT retinal disease screening system

Ping An Technology, along with Optovue, has developed the first artificial intelligence (AI) imaging and screening system, which seamlessly incorporates an OCT retinal imaging device and AI lesion

More From BioPortfolio on "Ping An concludes clinical study for world’s first OCT retinal disease screening system"